REACTIVE: Spine Rehabilitation Using Spine Flexion / Extension Full Active Range of Motion for Patients With Chronic Low Back Pain

Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace (Other)
Overall Status
Recruiting
CT.gov ID
NCT05213845
Collaborator
(none)
65
1
1
15.4
4.2

Study Details

Study Description

Brief Summary

The main objective of this study is to assess efficacy of a spine rehabilitation program, using spine flexion and extension full active range of motion, on physical disability of patients with chronic low back pain.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Spine flexion/extension active range of motion exercises
N/A

Detailed Description

Secondary objectives

The other objectives of this study are to assess the impact of spine rehabiliation program using spine flexion and extension full active range of motion on :

  • pain intensity ;

  • kinesiophobia

  • active range of motion of lumbar flexion and lumbar extension

Conduct of research

After receiving the written consent of the study, participants will benefit from 5 sessions of spine flexion and extension full active range of motion exercises. The following tests and questionnaires will be performed before (baseline) and after (posttreatment) the 5 sessions :

  • Visual Analogue Pain Scale,

  • Fear Avoidance Beliefs Questionnaire (FABQ),

  • Double-inclinometer to measure active range of motion of lumbar flexion and lumbar extension.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
65 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assessment of Spine Rehabilitation Program Using Spine Flexion and Extension Full Active Range of Motion for Patients With Chronic Low Back Pain : a Monocentric Prospective Cohort Study
Actual Study Start Date :
Feb 17, 2022
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Patients with chronic low back pain

Procedure: Spine flexion/extension active range of motion exercises
Five full active range of motion rehabilitation sessions will be scheduled. Four or the five following full active range of motion exercises will be performed during one rehabilitation session : spine flexion and extension (quadrupedic position), lumbar flexion and extension (sitting position), posterior and anterior pelvic tilt (sitting and standing position), lumbar flexion and extension (standing position) and Jefferson Curl exercise. All five rehabilitation sessions must be performed within 60 days

Outcome Measures

Primary Outcome Measures

  1. Roland-Morris disability questionnaire [Posttreatment (2 months)]

    The Roland-Morris questionnaire is a 24-item self report questionnaire assessing physical disability, ranging from 0 (no disability) to 24 (severe disability).

Secondary Outcome Measures

  1. Pain intensity [Posttreatment (2 months)]

    Pain intensity will be measured with a Visual Analog Pain Scale, from 0 (no pain) to 10 (pain of maximum intensity)

  2. Fear Avoidance Beliefs Questionnaire (FABQ) [Posttreatment (2 months)]

    The FABQ is a patient reported questionnaire which specifically focuses on how patient's fear-avoidance beliefs about physical activity may affect and contribute to his/her low back pain and resulting disability.

  3. Active range of motion of lumbar flexion and lumbar extension [Posttreatment (2 months)]

    Active range of motion of lumbar flexion and lumbar extension will be measured with two inclinometers.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Medical prescription for chronic low back pain rehabilitation

  • Evolution of low back pain for at least 3 months

  • No treatment or rehabilitation for low back pain performed within 12 months before enrollment

  • Written informed consent given

Exclusion Criteria:
  • Spinal fracture or previous spinal surgery

  • Cognitive impairments that prevent from understanding the rehabilitation exercises

  • Patient with insufficient understanding or expression in French

  • Non-mechanical pain : gradually worsening pain, present at rest and especially at night

  • Neurological symptom : deficit in the control of bladder and anal sphincters, motor weakness of lower limbs, Cauda equina syndrome

  • Pubis paresthesia (or perineum)

  • Severe trauma (such as fall from height, traffic accident)

  • Unexplained weight loss

  • History of cancer

  • Drug use or long-term use of corticosteroid

  • Spinal deformity

  • Altered general condition

  • Patient with signs of neurological impairment : positive Lasegue test (Straight Leg Raise Test) or positive Slump test, or DN4 questionnaire greater than or equal to 4

  • Patient suffering from a central or peripheral neurological pathology

  • Patient taking a level II (weak opiates) or III (morphine and related substances) analgesic treatment

  • Patient under guardianship, curatorship or legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cabinet de masso-kinésithérapie Mulhouse France 68100

Sponsors and Collaborators

  • Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
ClinicalTrials.gov Identifier:
NCT05213845
Other Study ID Numbers:
  • GHR 1206
  • 2021-A02319-32
First Posted:
Jan 28, 2022
Last Update Posted:
Jun 13, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 13, 2022